Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells:: Involvement of NF-κB and ERK signaling pathways

被引:225
作者
Park, Jin-Sun
Lee, Eun-Jung
Lee, Jae-Chul
Kim, Won-Ki
Kim, Hee-Sun
机构
[1] Ewha Womans Univ, Coll Med, Dept Neurosci, Seoul 158710, South Korea
[2] Ewha Womans Univ, Coll Med, Med Res Inst, Seoul 158710, South Korea
关键词
short chain fatty acids; macrophage; cytokine; iNOS; NF-kappa B; ERK;
D O I
10.1016/j.intimp.2006.08.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The overactivation of macrophages causes abnormal cell death and chronic inflammatory diseases. Therefore, the modulation of macrophage-mediated cytotoxicity is expected to become a new therapeutic strategy for various inflammatory diseases. In this study, three types of short chain fatty acids (sodium butyrate (NaB), sodium phenylbutyrate (NaPB), sodium phenylacetate (NaPA)) were found to have anti-inflammatory effects in IFN-gamma-stimulated RAW 264.7 cells. They inhibited the expression of iNOS, TNF-alpha, and IL-6 induced by IFN-gamma, while they enhanced the expression of the anti-inflammatory cytokine, IL-10. Their potency as anti-inflammatory agents was in the order of NaB > NaPB > NaPA. Further mechanistic studies revealed these three agents to repress the DNA binding and transcriptional activities of NF-kappa B, which is an important modulator of inflammation. In addition, these agents repressed the IFN-gamma-induced ERK1/2 phosphorylation without affecting the Jak/STAT activities. The potency of NF-kappa B and ERK inhibition was also in the order of NaB > NaPB > NaPA. The results suggest that the NF-kappa B and ERK signaling pathways are at least in part involved in the anti-inflammatory activities of these SCFAs. Considering that SCFAs are normally present in the body and have few side effects, they might be promising agents for the prevention and/or treatment of various inflammatory diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 37 条
  • [1] Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation
    Berlato, C
    Cassatella, MA
    Kinjyo, I
    Gatto, L
    Yoshimura, A
    Bazzoni, F
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (12) : 6404 - 6411
  • [2] Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat
    Butzner, JD
    Parmar, R
    Bell, CJ
    Dalal, V
    [J]. GUT, 1996, 38 (04) : 568 - 573
  • [3] Carducci M., 1997, Anticancer Research, V17, P3972
  • [4] The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells
    Chakravortty, D
    Koide, N
    Kato, Y
    Sugiyama, T
    Mu, MM
    Yoshida, T
    Yokochi, T
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2000, 6 (03): : 243 - 247
  • [5] Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
    Chang, F
    Steelman, LS
    Lee, JT
    Shelton, JG
    Navolanic, PM
    Blalock, WL
    Franklin, RA
    McCubrey, JA
    [J]. LEUKEMIA, 2003, 17 (07) : 1263 - 1293
  • [6] Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?
    Chen, James S.
    Faller, Douglas V.
    Spanjaard, Remco A.
    [J]. CURRENT CANCER DRUG TARGETS, 2003, 3 (03) : 219 - 236
  • [7] Inhibition of histone deacetylase activity by butyrate
    Davie, JR
    [J]. JOURNAL OF NUTRITION, 2003, 133 (07) : 2485S - 2493S
  • [8] The inflammatory macrophage: a story of Jekyll and Hyde
    Duffield, JS
    [J]. CLINICAL SCIENCE, 2003, 104 (01) : 27 - 38
  • [9] FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
  • [10] Fuss IJ, 1996, J IMMUNOL, V157, P1261